US FDA Notes Concerns At Multiple Formula Plants After One Linked To Contamination, Shortage

Commissioner, CFSAN Director Give 'Call To Action' In Letters To Manufacturers

Agency sends letters to manufacturers and other businesses involved in production and distribution “to assist industry in improving the microbiological safety of powdered infant formula.” Information from “routine surveillance inspections” of facilities and “for-cause inspections to follow up on consumer complaints” noted in letters.

• Source: Shutterstock

One firm's manufacturing facility has been linked to contaminated powder infant formula products that led to a US supply shortage in 2022 but the Food and Drug Administration has found quality-control problems at plants or other facilities operated by multiple businesses.

The agency has submitted letters to manufacturers and other businesses involved in production and distribution “to assist industry in improving the microbiological safety of powdered infant formula” with information including...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation